Skip to main content
Journal cover image

D-Dimer elevation and adverse outcomes.

Publication ,  Journal Article
Halaby, R; Popma, CJ; Cohen, A; Chi, G; Zacarkim, MR; Romero, G; Goldhaber, SZ; Hull, R; Hernandez, A; Mentz, R; Harrington, R; Lip, G ...
Published in: J Thromb Thrombolysis
January 2015

D-Dimer is a biomarker of fibrin formation and degradation. While a D-dimer within normal limits is used to rule out the diagnosis of deep venous thrombosis and pulmonary embolism among patients with a low clinical probability of venous thromboembolism (VTE), the prognostic association of an elevated D-dimer with adverse outcomes has received far less emphasis. An elevated D-dimer is independently associated with an increased risk for incident VTE, recurrent VTE, and mortality. An elevated D-dimer is an independent correlate of increased mortality and subsequent VTE across a broad variety of disease states. Therefore, medically ill subjects in whom the D-dimer is elevated constitute a high risk subgroup in which the prospective evaluation of the efficacy and safety of antithrombotic therapy is warranted.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Thromb Thrombolysis

DOI

EISSN

1573-742X

Publication Date

January 2015

Volume

39

Issue

1

Start / End Page

55 / 59

Location

Netherlands

Related Subject Headings

  • Venous Thrombosis
  • Venous Thromboembolism
  • Male
  • Humans
  • Fibrinolytic Agents
  • Fibrin Fibrinogen Degradation Products
  • Female
  • Cardiovascular System & Hematology
  • Biomarkers
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Halaby, R., Popma, C. J., Cohen, A., Chi, G., Zacarkim, M. R., Romero, G., … Gibson, C. M. (2015). D-Dimer elevation and adverse outcomes. J Thromb Thrombolysis, 39(1), 55–59. https://doi.org/10.1007/s11239-014-1101-6
Halaby, Rim, Christopher J. Popma, Ander Cohen, Gerald Chi, Marcelo Rodrigues Zacarkim, Gonzalo Romero, Samuel Z. Goldhaber, et al. “D-Dimer elevation and adverse outcomes.J Thromb Thrombolysis 39, no. 1 (January 2015): 55–59. https://doi.org/10.1007/s11239-014-1101-6.
Halaby R, Popma CJ, Cohen A, Chi G, Zacarkim MR, Romero G, et al. D-Dimer elevation and adverse outcomes. J Thromb Thrombolysis. 2015 Jan;39(1):55–9.
Halaby, Rim, et al. “D-Dimer elevation and adverse outcomes.J Thromb Thrombolysis, vol. 39, no. 1, Jan. 2015, pp. 55–59. Pubmed, doi:10.1007/s11239-014-1101-6.
Halaby R, Popma CJ, Cohen A, Chi G, Zacarkim MR, Romero G, Goldhaber SZ, Hull R, Hernandez A, Mentz R, Harrington R, Lip G, Peacock F, Welker J, Martin-Loeches I, Daaboul Y, Korjian S, Gibson CM. D-Dimer elevation and adverse outcomes. J Thromb Thrombolysis. 2015 Jan;39(1):55–59.
Journal cover image

Published In

J Thromb Thrombolysis

DOI

EISSN

1573-742X

Publication Date

January 2015

Volume

39

Issue

1

Start / End Page

55 / 59

Location

Netherlands

Related Subject Headings

  • Venous Thrombosis
  • Venous Thromboembolism
  • Male
  • Humans
  • Fibrinolytic Agents
  • Fibrin Fibrinogen Degradation Products
  • Female
  • Cardiovascular System & Hematology
  • Biomarkers
  • 3202 Clinical sciences